207 related articles for article (PubMed ID: 26316056)
1. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort.
Anton J; Calvo I; Fernández-Martin J; Gamir ML; Merino R; Jimenez-Treviño S; Sevilla B; Cabades F; Bou R; Arostegui JI
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S67-71. PubMed ID: 26243511
[TBL] [Abstract][Full Text] [Related]
3. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
[TBL] [Abstract][Full Text] [Related]
4. Neonatal treatment of CINCA syndrome.
Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
[TBL] [Abstract][Full Text] [Related]
5. Muckle-Wells syndrome effectively treated with canakinumab: is the recommended dosing schedule mandatory?
Mueller SM; Itin P; Haeusermann P
Dermatology; 2011; 223(2):113-8. PubMed ID: 21967869
[TBL] [Abstract][Full Text] [Related]
6. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
Goldbach-Mansky R
Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
[TBL] [Abstract][Full Text] [Related]
7. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
[TBL] [Abstract][Full Text] [Related]
8. Twenty year follow up of a patient with a new de-novo NLRP3 mutation (S595G) and CINCA syndrome.
Kanariou M; Dracou C; Spanou K; Möller J; Rösen-Wolff A; Schuster V; Roesler J
Klin Padiatr; 2009; 221(6):379-81. PubMed ID: 19890791
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts.
Sarrabay G; Grandemange S; Touitou I
Expert Rev Clin Immunol; 2015; 11(7):827-35. PubMed ID: 25979514
[TBL] [Abstract][Full Text] [Related]
10. Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes.
Cantarini L; Lucherini OM; Frediani B; Brizi MG; Bartolomei B; Cimaz R; Galeazzi M; Rigante D
Int J Immunopathol Pharmacol; 2011; 24(4):827-36. PubMed ID: 22230390
[TBL] [Abstract][Full Text] [Related]
11. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study.
Tanaka N; Izawa K; Saito MK; Sakuma M; Oshima K; Ohara O; Nishikomori R; Morimoto T; Kambe N; Goldbach-Mansky R; Aksentijevich I; de Saint Basile G; Neven B; van Gijn M; Frenkel J; Aróstegui JI; Yagüe J; Merino R; Ibañez M; Pontillo A; Takada H; Imagawa T; Kawai T; Yasumi T; Nakahata T; Heike T
Arthritis Rheum; 2011 Nov; 63(11):3625-32. PubMed ID: 21702021
[TBL] [Abstract][Full Text] [Related]
12. [Cryopyrin-associated periodic syndromes].
Quartier P; Rodrigues F; Georgin-Lavialle S
Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery.
Tanaka T; Takahashi K; Yamane M; Tomida S; Nakamura S; Oshima K; Niwa A; Nishikomori R; Kambe N; Hara H; Mitsuyama M; Morone N; Heuser JE; Yamamoto T; Watanabe A; Sato-Otsubo A; Ogawa S; Asaka I; Heike T; Yamanaka S; Nakahata T; Saito MK
Blood; 2012 Aug; 120(6):1299-308. PubMed ID: 22723549
[TBL] [Abstract][Full Text] [Related]
14. Successful management of cryopyrin-associated periodic syndrome with canakinumab in infancy.
Kanariou M; Tantou S; Varela I; Raptaki M; Petropoulou C; Nikas I; Valari M
Pediatrics; 2014 Nov; 134(5):e1468-73. PubMed ID: 25349319
[TBL] [Abstract][Full Text] [Related]
15. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome.
Saito M; Fujisawa A; Nishikomori R; Kambe N; Nakata-Hizume M; Yoshimoto M; Ohmori K; Okafuji I; Yoshioka T; Kusunoki T; Miyachi Y; Heike T; Nakahata T
Arthritis Rheum; 2005 Nov; 52(11):3579-85. PubMed ID: 16255047
[TBL] [Abstract][Full Text] [Related]
16. Switch from anakinra to canakinumab in a severe case of CINCA syndrome.
Rigante D; Verrecchia E; Falsini B; Manna R
Int J Rheum Dis; 2016 Dec; 19(12):1354-1356. PubMed ID: 26585548
[No Abstract] [Full Text] [Related]
17. [Update in interleukin-1 inhibition].
de Boysson H
Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
[No Abstract] [Full Text] [Related]
18. A novel mutation in the CIAS1/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes.
Insalaco A; Prencipe G; Buonuomo PS; Ceccherini I; Bracaglia C; Pardeo M; Nicolai R; De Benedetti F
Clin Exp Rheumatol; 2014; 32(1):123-5. PubMed ID: 24144430
[TBL] [Abstract][Full Text] [Related]
19. An Adult Patient With a Novel Mutation in NLRP3 Gene Associated With Cryopyrin-Associated Periodic Syndrome Mimicking Adult-Onset Still Disease.
Ocampo V; Ortiz-Sierra MC; Echeverri AF; Posso-Osorio I; Suso JP; Tobón GJ
J Clin Rheumatol; 2018 Apr; 24(3):158-159. PubMed ID: 29239927
[No Abstract] [Full Text] [Related]
20. Anakinra for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2014 Jan; 10(1):7-18. PubMed ID: 24308832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
